Ischemic heart disease decisions — 2025

The Board remands the claims for service connection for ischemic heart disease, cardiomyopathy, a prostate disorder, diabetes mellitus, and hypertension to obtain additional evidence regarding toxic exposure risk activities during the Veteran's service.

The Board denied service connection for a heart disability, to include ischemic heart disease and aortic valve disease with aortic valve replacement, as the evidence did not support a finding that these conditions began during active service or are otherwise related to an in-service injury or disease.

The Board granted service connection for an acquired psychiatric disorder, but remanded the claims for a heart disability and bilateral restless leg syndrome.

The Board granted service connection for hypertensive vascular disease (claimed as a heart disorder) based on the Veteran's participation in toxic exposure risk activities during his military service.

The Board denied service connection for diabetes mellitus, type II, a skin disorder, and a heart disorder as the evidence did not support a finding that these conditions were related to the Veteran's active military service.

The Board remands the claims for service connection for various disabilities, including a heart disorder, neck artery disability, leg bypass surgery and residuals thereof, kidney transplant and residuals thereof, and left to right leg artery transplant and residuals thereof, as there has not been substantial compliance with previous remand directives.

The Board denied service connection for hypertension, a heart disorder, and erectile dysfunction as the evidence did not support a causal relationship between these conditions and the Veteran's military service.

The Board denied service connection for coronary artery disease, hypertension, a seizure disability, peripheral vascular disease, chronic kidney disease, and diabetes mellitus as the record does not show that these conditions were incurred in or caused by service.

The Board remands the claims for service connection for coronary artery disease with congestive heart failure and hypertension, to include as due to herbicide agent exposure, for further development of the record.

The Board denied an initial compensable rating for bilateral hearing loss and remanded the claims for service connection for diabetes mellitus Type II, hypertension, and coronary artery disease.

The Board denied higher staged ratings for ischemic heart disease, hypertension, and PTSD but granted a total disability rating based on individual unemployability (TDIU) from August 1, 2022.

The Board granted service connection for coronary artery disease and diabetes mellitus, type 2 due to the Veteran's exposure to herbicide agents during his service in Korea. The claim for a brain tumor was remanded for further development.

The Board denied the claims for earlier effective dates, service connection for various conditions, and remanded some issues for further development.

The Board denied service connection for hypertension and remanded the claim for heart disease, to include non-ischemic cardiomyopathy.

The appeals for an effective date prior to June 28, 2023 for the grant of service connection for coronary artery disease, a disability rating higher than 30 percent for coronary artery disease, and a compensable disability rating for hypertension were dismissed due to duplicate claims in the system.

The Board remands the issues of entitlement to an initial rating in excess of 10 percent prior to January 25, 2016, in excess of 30 percent from January 25, 2016, to January 21, 2020, and in excess of 60 percent thereafter for coronary artery disease, myocardial infarction, and PTCA (CAD) and entitlement to a total disability rating based upon individual unemployability due to service-connected disabilities (TDIU) prior to August 10, 2022, as the case requires additional development.

The Board remands the claims for service connection due to a lack of complete Reserve service records and unclear in-service toxic exposures.

The Board remands the claims for a retrospective medical opinion addressing the severity of the Veteran's CAD prior to January 18, 2024, and TDIU.

The Board granted an initial 60 percent rating for hypertensive heart disease, a separate 10 percent rating for hypothyroidism residuals, urinary symptoms, and a separate 10 percent rating for hypothyroidism residuals, gastrointestinal symptoms. A 20 percent rating was also granted for dry eye syndrome and pseudophakia due to cataract extraction, associated with hypothyroidism.

The Veteran's PTSD was granted a 50% rating from September 27, 2021 to March 8, 2023; however, ratings in excess of 50% and 70% were denied. The claims for earlier effective dates for service connection for coronary artery disease, left lower extremity diabetic peripheral neuropathy, and right lower extremity diabetic peripheral neuropathy were also denied.